Evidence map›Paper›PMID 39119897›Full record

ArticleNucleic acids research2024

Invention of circRNA promoting RNA to specifically promote circRNA production.

Zhilin He, Haofei Ji, Bei Xia, Xiuen Cao, Ying Huang, Qubo Zhu

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Acta pharmaceutica Sinica. B · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhilin HeXiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China.
Haofei JiXiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China.
Bei XiaXiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China.
Xiuen CaoXiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China.
Ying HuangXiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China.
Qubo ZhuXiangya School of Pharmaceutical Sciences in Central South University, Changsha, Hunan 410013, China.ORCID 0009-0004-9101-7189

Funding

Hunan Provincial Natural Science Foundation for Distinguished Young Scholars 2022JJ10091Hunan Provincial Natural Science Foundation of China 2021JJ30916National Natural Science Foundation of China C0602-32270609
6 · The paper itself

Abstract

CircRNA, an essential RNA molecule involved in various biological functions and diseases, often exhibits decreased expression in tumor tissues, playing a role as a tumor suppressor, and suggesting therapeutic potential for cancer. However, current methods for promoting circRNA production are limited. This study introduces a novel approach for enhancing circRNA biogenesis, termed circRNA promoting RNA (cpRNA). CpRNA is designed to complement the flanking sequences of reverse complementary matches (RCMs) within pre-mRNA, thereby facilitating circRNA formation through improved exon circularization. Using a split-GFP reporter system, we demonstrated that cpRNA significantly enhance circGFP production. Optimization identified the best conditions for cpRNA to promote circRNA biogenesis, and these cpRNAs were then used to augment the production of endogenous circRNAs. These results indicate that cpRNAs can specifically increase the production of endogenous circRNAs with RCMs, such as circZKSCAN1 and circSMARCA5 in cancer cells, thereby inhibiting cell proliferation and migration by modulating circRNA-related pathways, showcasing the therapeutic potential of cpRNAs. Mechanistic studies have also shown that cpRNA promotes circRNA biogenesis, in part, by antagonizing the unwinding function of DHX9. Overall, these findings suggest that cpRNA represents a promising strategy for circRNA overexpression, offering a potential treatment for diseases marked by low circRNA levels.

Indexed as

Cell ProliferationRNA, CircularCell Line, TumorCell MovementDEAD-box RNA HelicasesHEK293 CellsHumansNeoplasm ProteinsNeoplasmsRNARNA PrecursorsDEAD-box RNA HelicasesDHX9 protein, humanNeoplasm ProteinsRNARNA, CircularRNA Precursors

Identifiers

PMID39119897
PMCPMC11417354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.